African scientists face challenges in responding to mpox virus mutation

Scientists studying the new mpox strain report that it is mutating faster than expected, creating uncertainties about the virus's characteristics, severity, and transmission. This rapid mutation complicates the response to the outbreak, which has been particularly severe in Africa. Despite the World Health Organization declaring a global health emergency, some areas lack the necessary funding and equipment to effectively track the virus's changes. Nigeria has received 10,000 doses of a vaccine to combat mpox, having secured them before the global health emergency was declared. However, the delay in providing vaccines to Africa has raised concerns about the international response to global health emergencies, with medical officials and scientists warning of worrying problems in the way international agencies deal with such crises.